Back to search

Article

Combating Metallo-β-Lactamase-Producing Pseudomonas aeruginosa: The Fractional Inhibitory Concentration Index as a Tool to Evaluate Antibiotic Synergy

2024-12-13

Abstract excerpt

<h4>Background: </h4> Multi-drug-resistant Gram negative bacteria producing metallo-β-lactamase are an increasing concern. Here we describe three cases of infection due to difficult to treat resistant P. aeruginosa producing metallo-β-lactamases, successfully treated with antibiotic combination of cefiderocol plus imipenem-relebactam and report on the molecular and epidemiological features of the isolates and the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
36d27db4-bae3-535e-b7ac-a737746ed6ad
DOI
10.20944/preprints202412.1056.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Combating Metallo-β-Lactamase-Producing Pseudomonas aeruginosa: The Fractional Inhibitory Concentration Index as a Tool to Evaluate Antibiotic SynergyDOI 10.20944/preprints202412.1056.v1
Imipenem Resistance: A Clarion Call to Antibiotic StewardshipSemantic proximity
Synergistic cefiderocol-containing antibiotic combinations active against highly drug-resistant <i>Acinetobacter baumannii</i> patient isolates with diverse resistance mechanismsSemantic proximity
Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative BacteriaSemantic proximity
In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosaSemantic proximity
Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative BacteriaSemantic proximity
Combating Multidrug Resistance in Escherichia coli and Klebsiella pneumoniae: A Synergistic Approach with Repurposed DrugsSemantic proximity
Combatting Pseudomonas aeruginosa with β-Lactam Antibiotics: A Revived Weapon?Semantic proximity
Molecular determinants associated with resistance to imipenem and imipenem–relebactam in clinical Pseudomonas aeruginosa isolatesSemantic proximity
Activity of imipenem/relebactam against Pseudomonas aeruginosa producing ESBLs and carbapenemasesSemantic proximity
In vitro activity of cefiderocol against Pseudomonas aeruginosa demonstrating evolved resistance to novel β-lactam/β-lactamase inhibitorsSemantic proximity
Activity of cefiderocol against Pseudomonas aeruginosa from the USA and Europe (2020-2023) with difficult-to-treat resistance phenotype, including those nonsusceptible to recently developed β-lactam/β-lactamase inhibitor combinations: results from the SENTRY antimicrobial surveillance program.Semantic proximity
Large scale phage-antibiotic combination studies reveal key combinations for urinary tract infection and urosepsis treatmentsSemantic proximity
Select a neighboring publication to make it the new centre.